Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma.
Minerva Endocrinol (Torino)
; 46(3): 367-369, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-32623844
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
RANK Ligand
/
Receptor Activator of Nuclear Factor-kappa B
/
Osteoprotegerin
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
Minerva Endocrinol (Torino)
Year:
2021
Document type:
Article
Affiliation country:
Italia
Country of publication:
Italia